{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:16:37Z","timestamp":1779394597738,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uromodulin (<jats:italic>UMOD<\/jats:italic>) encodes an uromodulin glycoprotein, and its mutation results in uromodulin glycoprotein dysfunction and the occurrence of gout. The aim of our study was to assess whether <jats:italic>UMOD<\/jats:italic> methylation could predict the risk of gout. A total of 89 sporadic gout cases and 103 age and gender-matched healthy controls were recruited in this study. <jats:italic>UMOD<\/jats:italic> methylation level was determined by quantitative methylation-specific PCR (qMSP) in peripheral blood, and the percentage of methylated reference (PMR) was described to represent the methylation level. Our results showed that <jats:italic>UMOD<\/jats:italic> methylation was significantly higher in gout cases than controls (median: 1.45 versus 0.75, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The area under curve (AUC) of <jats:italic>UMOD<\/jats:italic> methylation in gout was 0.764 (<jats:italic>P<\/jats:italic>\u2009=\u20092.90E-10) with a sensitivity of 65.2% and a specificity of 88.3%. <jats:italic>UMOD<\/jats:italic> methylation level was shown to be significantly correlated with the serum level of uric acid (UA) (r\u2009=\u2009\u22120.208, <jats:italic>P<\/jats:italic>\u2009=\u20090.035). Besides, the luciferase reporter assay showed that <jats:italic>UMOD<\/jats:italic> CpG island region was able to upregulate gene expression (fold change\u2009=\u20092, <jats:italic>P<\/jats:italic>\u2009=\u20090.004). In conclusion, <jats:italic>UMOD<\/jats:italic> methylation assessment might be used to predict the occurrence of gout.<\/jats:p>","DOI":"10.1038\/s41598-017-11627-w","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T14:42:39Z","timestamp":1504622559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Elevated UMOD methylation level in peripheral blood is associated with gout risk"],"prefix":"10.1038","volume":"7","author":[{"given":"Yong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"11627_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang, W. et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the rheumatic diseases \n                           65, 1301\u20131311, doi:10.1136\/ard.2006.055251 (2006).","journal-title":"Annals of the rheumatic diseases"},{"key":"11627_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. The American journal of medicine \n                           125, 679\u2013687 e671, doi:10.1016\/j.amjmed.2011.09.033 (2012).","journal-title":"The American journal of medicine"},{"key":"11627_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5648","volume":"347","author":"E Roddy","year":"2013","unstructured":"Roddy, E., Mallen, C. D. & Doherty, M. Gout. Bmj \n                           347, f5648, doi:10.1136\/bmj.f5648 (2013).","journal-title":"Bmj"},{"key":"11627_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","volume":"76","author":"A Nakayama","year":"2017","unstructured":"Nakayama, A. et al. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Annals of the rheumatic diseases \n                           76, 869\u2013877, doi:10.1136\/annrheumdis-2016-209632 (2017).","journal-title":"Annals of the rheumatic diseases"},{"key":"11627_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089128","volume":"9","author":"J Cheng","year":"2014","unstructured":"Cheng, J. et al. Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. PloS one \n                           9, e89128, doi:10.1371\/journal.pone.0089128 (2014).","journal-title":"PloS one"},{"key":"11627_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.16288\/j.yczz.14-327","volume":"37","author":"C Xiaoying","year":"2015","unstructured":"Xiaoying, C. et al. [The effects of DNA methylation on the homeostasis in vascular diseases]. Yi chuan\u2009=\u2009Hereditas \n                           37, 221\u2013232, doi:10.16288\/j.yczz.14-327 (2015).","journal-title":"Yi chuan\u2009=\u2009Hereditas"},{"key":"11627_CR7","doi-asserted-by":"publisher","first-page":"81255","DOI":"10.18632\/oncotarget.13221","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma. Oncotarget \n                           7, 81255\u201381267, doi:10.18632\/oncotarget.13221 (2016).","journal-title":"Oncotarget"},{"key":"11627_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/hr.2014.172","volume":"38","author":"L Han","year":"2015","unstructured":"Han, L. et al. The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study. Hypertension research: official journal of the Japanese Society of Hypertension \n                           38, 284\u2013290, doi:10.1038\/hr.2014.172 (2015).","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"key":"11627_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096822","volume":"9","author":"D Jiang","year":"2014","unstructured":"Jiang, D. et al. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis. PloS one \n                           9, e96822, doi:10.1371\/journal.pone.0096822 (2014).","journal-title":"PloS one"},{"key":"11627_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110773","volume":"9","author":"L Chang","year":"2014","unstructured":"Chang, L. et al. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer\u2019s disease. PloS one \n                           9, e110773, doi:10.1371\/journal.pone.0110773 (2014).","journal-title":"PloS one"},{"key":"11627_CR11","first-page":"11356","volume":"8","author":"L Jian","year":"2015","unstructured":"Jian, L., Fa, X., Zhou, Z. & Liu, S. Functional analysis of UMOD gene and its effect on inflammatory cytokines in serum of essential hypertension patients. International journal of clinical and experimental pathology \n                           8, 11356\u201311363 (2015).","journal-title":"International journal of clinical and experimental pathology"},{"key":"11627_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/BOR.0b013e32834f049f","volume":"24","author":"TH Gibson","year":"2012","unstructured":"Gibson, T. H. gout and the kidney. Current opinion in rheumatology \n                           24, 127\u2013131, doi:10.1097\/BOR.0b013e32834f049f (2012).","journal-title":"Current opinion in rheumatology"},{"key":"11627_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ng.377","volume":"41","author":"A Kottgen","year":"2009","unstructured":"Kottgen, A. et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nature genetics \n                           41, 712\u2013717, doi:10.1038\/ng.377 (2009).","journal-title":"Nature genetics"},{"key":"11627_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001177","volume":"6","author":"S Padmanabhan","year":"2010","unstructured":"Padmanabhan, S. et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS genetics \n                           6, e1001177, doi:10.1371\/journal.pgen.1001177 (2010).","journal-title":"PLoS genetics"},{"key":"11627_CR15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/nm.3384","volume":"19","author":"M Trudu","year":"2013","unstructured":"Trudu, M. et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nature medicine \n                           19, 1655\u20131660, doi:10.1038\/nm.3384 (2013).","journal-title":"Nature medicine"},{"key":"11627_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002292","volume":"7","author":"CA Boger","year":"2011","unstructured":"Boger, C. A. et al. Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS genetics \n                           7, e1002292, doi:10.1371\/journal.pgen.1002292 (2011).","journal-title":"PLoS genetics"},{"key":"11627_CR17","first-page":"71","volume":"10","author":"RL Nath","year":"1962","unstructured":"Nath, R. L. & Ghosh, N. K. A preliminary report on the determination of the normal values of serum alkaline phosphatase activity by velocity constant method. Bulletin of the Calcutta School of Tropical Medicine \n                           10, 71\u201372 (1962).","journal-title":"Bulletin of the Calcutta School of Tropical Medicine"},{"key":"11627_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2116\/analsci.26.1193","volume":"26","author":"X Yang","year":"2010","unstructured":"Yang, X. et al. Kinetic analysis of the lactate-dehydrogenase-coupled reaction process and measurement of alanine transaminase by an integration strategy. Analytical sciences: the international journal of the Japan Society for Analytical Chemistry \n                           26, 1193\u20131198 (2010).","journal-title":"Analytical sciences: the international journal of the Japan Society for Analytical Chemistry"},{"key":"11627_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0003-2697(69)90164-X","volume":"28","author":"G Asrow","year":"1969","unstructured":"Asrow, G. Semiautomated enzymic micro methods for blood glucose and lactic acid on a single filtrate. Analytical biochemistry \n                           28, 130\u2013138 (1969).","journal-title":"Analytical biochemistry"},{"key":"11627_CR20","first-page":"89","volume":"13","author":"P Hunziker","year":"1975","unstructured":"Hunziker, P. & Keller, H. [A mechanized enzymic method for the determination of uric acid (author\u2019s transl)]. Zeitschrift fur klinische Chemie und klinische Biochemie \n                           13, 89\u201396 (1975).","journal-title":"Zeitschrift fur klinische Chemie und klinische Biochemie"},{"key":"11627_CR21","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/clinchem\/24.11.2018","volume":"24","author":"K Whitlow","year":"1978","unstructured":"Whitlow, K. & Gochman, N. Continuous-flow enzymic method evaluated for measurement of serum triglycerides with use of an improved lipase reagent. Clinical chemistry \n                           24, 2018\u20132019 (1978).","journal-title":"Clinical chemistry"},{"key":"11627_CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/clinchem\/28.1.114","volume":"28","author":"PK Jaynes","year":"1982","unstructured":"Jaynes, P. K., Feld, R. D. & Johnson, G. F. An enzymic, reaction-rate assay for serum creatinine with a centrifugal analyzer. Clinical chemistry \n                           28, 114\u2013117 (1982).","journal-title":"Clinical chemistry"},{"key":"11627_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/2040622316658459","volume":"7","author":"SM Bahijri","year":"2016","unstructured":"Bahijri, S. M. et al. The relationship of management modality in Saudi patients with type 2 diabetes to components of metabolic syndrome, gamma glutamyl transferase and highly sensitive C-reactive protein. Therapeutic advances in chronic disease \n                           7, 246\u2013254, doi:10.1177\/2040622316658459 (2016).","journal-title":"Therapeutic advances in chronic disease"},{"key":"11627_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5114\/aoms.2014.47879","volume":"12","author":"D Xie","year":"2016","unstructured":"Xie, D. et al. Increased high-sensitivity C-reactive protein, erythrocyte sedimentation rate and lactic acid in stroke patients with internal carotid artery occlusion. Archives of medical science: AMS \n                           12, 546\u2013551, doi:10.5114\/aoms.2014.47879 (2016).","journal-title":"Archives of medical science: AMS"},{"key":"11627_CR25","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.038","volume":"25","author":"A Nakadate","year":"2016","unstructured":"Nakadate, A. et al. Age, Body Mass Index, and White Blood Cell Count Predict the Resumption of Oral Intake in Subacute Stroke Patients. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association \n                           25, 2801\u20132808, doi:10.1016\/j.jstrokecerebrovasdis.2016.07.038 (2016).","journal-title":"Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association"},{"key":"11627_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2353\/jmoldx.2006.050135","volume":"8","author":"S Ogino","year":"2006","unstructured":"Ogino, S. et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. The Journal of molecular diagnostics: JMD \n                           8, 209\u2013217, doi:10.2353\/jmoldx.2006.050135 (2006).","journal-title":"The Journal of molecular diagnostics: JMD"},{"key":"11627_CR27","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.clinbiochem.2016.08.002","volume":"49","author":"Z Shen","year":"2016","unstructured":"Shen, Z. et al. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients. Clinical biochemistry \n                           49, 1278\u20131282, doi:10.1016\/j.clinbiochem.2016.08.002 (2016).","journal-title":"Clinical biochemistry"},{"key":"11627_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2015.08.027","volume":"606","author":"H Ji","year":"2015","unstructured":"Ji, H. et al. OPRK1 promoter hypermethylation increases the risk of Alzheimer\u2019s disease. Neuroscience letters \n                           606, 24\u201329, doi:10.1016\/j.neulet.2015.08.027 (2015).","journal-title":"Neuroscience letters"},{"key":"11627_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-016-0515-y","volume":"17","author":"C Morris","year":"2016","unstructured":"Morris, C., Macdonald, L., Stubbe, M. & Dowell, A. \u201cIt\u2019s complicated\u201d - talking about gout medicines in primary care consultations: a qualitative study. BMC family practice \n                           17, 114, doi:10.1186\/s12875-016-0515-y (2016).","journal-title":"BMC family practice"},{"key":"11627_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1024\/0040-5930\/a000767","volume":"73","author":"B Ankli","year":"2016","unstructured":"Ankli, B. Current epidemiology of gout. Therapeutische Umschau. Revue therapeutique \n                           73, 125\u2013129, doi:10.1024\/0040-5930\/a000767 (2016).","journal-title":"Therapeutische Umschau. Revue therapeutique"},{"key":"11627_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1515\/bjmg-2015-0081","volume":"18","author":"S Karachanak-Yankova","year":"2015","unstructured":"Karachanak-Yankova, S. et al. Epigenetic alterations in patients with type 2 diabetes mellitus. Balkan journal of medical genetics: BJMG \n                           18, 15\u201324, doi:10.1515\/bjmg-2015-0081 (2015).","journal-title":"Balkan journal of medical genetics: BJMG"},{"key":"11627_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2015-2855","volume":"101","author":"I Sakuma","year":"2016","unstructured":"Sakuma, I. et al. Cushing Syndrome Due to ACTH-Secreting Pheochromocytoma, Aggravated by Glucocorticoid-Driven Positive-Feedback Loop. The Journal of clinical endocrinology and metabolism \n                           101, 841\u2013846, doi:10.1210\/jc.2015-2855 (2016).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"11627_CR33","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.metabol.2004.04.016","volume":"53","author":"T Inokuchi","year":"2004","unstructured":"Inokuchi, T. et al. Identification of a new point mutation in hypoxanthine phosphoribosyl transferase responsible for hyperuricemia in a female patient. Metabolism: clinical and experimental \n                           53, 1500\u20131502 (2004).","journal-title":"Metabolism: clinical and experimental"},{"key":"11627_CR34","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/ndt\/gfu300","volume":"30","author":"F Scolari","year":"2015","unstructured":"Scolari, F., Izzi, C. & Ghiggeri, G. M. Uromodulin: from monogenic to multifactorial diseases. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association \n                           30, 1250\u20131256, doi:10.1093\/ndt\/gfu300 (2015).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"11627_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078337","volume":"8","author":"E Kemter","year":"2013","unstructured":"Kemter, E. et al. Standardized, systemic phenotypic analysis of Umod(C93F) and Umod(A227T) mutant mice. PloS one \n                           8, e78337, doi:10.1371\/journal.pone.0078337 (2013).","journal-title":"PloS one"},{"key":"11627_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005798","volume":"96","author":"A Leiherer","year":"2017","unstructured":"Leiherer, A. et al. Serum uromodulin is associated with impaired glucose metabolism. Medicine \n                           96, e5798, doi:10.1097\/MD.0000000000005798 (2017).","journal-title":"Medicine"},{"key":"11627_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1515\/cclm-2014-0505","volume":"52","author":"L Risch","year":"2014","unstructured":"Risch, L. et al. The serum uromodulin level is associated with kidney function. Clinical chemistry and laboratory medicine \n                           52, 1755\u20131761, doi:10.1515\/cclm-2014-0505 (2014).","journal-title":"Clinical chemistry and laboratory medicine"},{"key":"11627_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003011","volume":"95","author":"D Steubl","year":"2016","unstructured":"Steubl, D. et al. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients. Medicine \n                           95, e3011, doi:10.1097\/MD.0000000000003011 (2016).","journal-title":"Medicine"},{"key":"11627_CR39","doi-asserted-by":"publisher","first-page":"F1066","DOI":"10.1152\/ajprenal.00543.2012","volume":"304","author":"TM El-Achkar","year":"2013","unstructured":"El-Achkar, T. M. et al. Tamm-Horsfall protein translocates to the basolateral domain of thick ascending limbs, interstitium, and circulation during recovery from acute kidney injury. American journal of physiology. Renal physiology \n                           304, F1066\u20131075, doi:10.1152\/ajprenal.00543.2012 (2013).","journal-title":"American journal of physiology. Renal physiology"},{"key":"11627_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature \n                           390, 45\u201351, doi:10.1038\/36285 (1997).","journal-title":"Nature"},{"key":"11627_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079856","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. Elevated Klotho promoter methylation is associated with severity of chronic kidney disease. PloS one \n                           8, e79856, doi:10.1371\/journal.pone.0079856 (2013).","journal-title":"PloS one"},{"key":"11627_CR42","first-page":"831","volume":"90","author":"BL Hainer","year":"2014","unstructured":"Hainer, B. L., Matheson, E. & Wilkes, R. T. Diagnosis, treatment, and prevention of gout. American family physician \n                           90, 831\u2013836 (2014).","journal-title":"American family physician"},{"key":"11627_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0587-7","volume":"18","author":"D Hyndman","year":"2016","unstructured":"Hyndman, D., Liu, S. & Miner, J. N. Urate Handling in the Human Body. Current rheumatology reports \n                           18, 34, doi:10.1007\/s11926-016-0587-7 (2016).","journal-title":"Current rheumatology reports"},{"key":"11627_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7326\/M16-0569","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem, A., McLean, R. M., Starkey, M. & Forciea, M. A. & Clinical Guidelines Committee of the American College of, P. Diagnosis of Acute Gout: A Clinical Practice Guideline From the American College of Physicians. Annals of internal medicine \n                           166, 52\u201357, doi:10.7326\/M16-0569 (2017).","journal-title":"Annals of internal medicine"},{"key":"11627_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna, D. et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis care & research \n                           64, 1431\u20131446, doi:10.1002\/acr.21772 (2012).","journal-title":"Arthritis care & research"},{"key":"11627_CR46","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/00325481.2016.1221732","volume":"128","author":"G Ruoff","year":"2016","unstructured":"Ruoff, G. & Edwards, N. L. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg\/dL? Postgraduate medicine \n                           128, 706\u2013715, doi:10.1080\/00325481.2016.1221732 (2016).","journal-title":"Postgraduate medicine"},{"key":"11627_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrrheum.2013.164","volume":"10","author":"FM McQueen","year":"2014","unstructured":"McQueen, F. M. Gout in 2013. Imaging, genetics and therapy: gout research continues apace. Nature reviews. Rheumatology \n                           10, 67\u201369, doi:10.1038\/nrrheum.2013.164 (2014).","journal-title":"Nature reviews. Rheumatology"},{"key":"11627_CR48","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/acr.22855","volume":"68","author":"A Abhishek","year":"2016","unstructured":"Abhishek, A., Valdes, A. M., Zhang, W. & Doherty, M. Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study. Arthritis care & research \n                           68, 1573\u20131577, doi:10.1002\/acr.22855 (2016).","journal-title":"Arthritis care & research"},{"key":"11627_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-62703-284-1_7","volume":"977","author":"YZ Xu","year":"2013","unstructured":"Xu, Y. Z., Kanagaratham, C., Jancik, S. & Radzioch, D. Promoter deletion analysis using a dual-luciferase reporter system. Methods in molecular biology \n                           977, 79\u201393, doi:10.1007\/978-1-62703-284-1_7 (2013).","journal-title":"Methods in molecular biology"},{"key":"11627_CR50","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gki441","volume":"33","author":"DS Chekmenev","year":"2005","unstructured":"Chekmenev, D. S., Haid, C. & Kel, A. E. P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic acids research \n                           33, W432\u2013437, doi:10.1093\/nar\/gki441 (2005).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11627-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11627-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11627-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:42:48Z","timestamp":1671792168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11627-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11627"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11627-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"23 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11196"}}